CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Amarin Corporation PLC - ADR Company Snapshot
Amarin Corporation PLC operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Amarin Corporation PLC with three other companies in this sector in the United States: Acadia Pharmaceuticals, Inc. (2018 sales of $223.81 million of which 100% was Molecular Drugs), Eagle Pharmaceuticals, Inc ($213.31 million of which 100% was Pharmaceuticals), and FibroGen Inc ($212.96 million of which 100% was Biopharmaceutical Preparations).

Sales Analysis. During the year ended December of 2018, sales at Amarin Corporation PLC were $229.21 million. This is an increase of 26.6% versus 2017, when the company's sales were $181.10 million. This was the fifth consecutive year of sales increases at Amarin Corporation PLC (and since 2013, sales have increased a total of 770%).
   
   
 
  Stock Performance Chart for Amarin Corporation PLC - ADR
 
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 15.22
(Figures in U.S. Dollars)
1 Week 5.9%   13 Weeks -8.9%  
4 Weeks -30.5%   52 Weeks -22.5%  
 
Amarin Corporation PLC - ADR Key Data:
  Ticker: AMRN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 229,214,871
(Year Ending Jan 2019).
Employees: 530
  Currency: U.S. Dollars Market Cap: 5,042,504,868
  Fiscal Yr Ends: December Shares Outstanding: 331,307,810
  Share Type: Ordinary Closely Held Shares: N/A
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.